Search research articles
Contact Us
Filters
Showing results (71-80 of 626) with videos related to
Page
of 63
Sort By:
Current Topics in Medicinal Chemistry
|
September 15, 2009
HIV-1 IN inhibitors: 2010 update and perspectives
Christophe Marchand, Kasthuraiah Maddali, Mathieu Métifiot, et al.
Acta Pharmacologica Sinica
|
June 1, 2004
Abrogation of Chk1-mediated S/G2 checkpoint by UCN-01 enhances ara-C-induced cytotoxicity in human colon cancer cells
Rong-Guang Shao, Chun-Xia Cao, Yves Pommier
Nature Communications
|
January 19, 2025
Structural insights into human topoisomerase 3β DNA and RNA catalysis and nucleic acid gate dynamics
Xi Yang, Xuemin Chen, Wei Yang, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
May 14, 2008
Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy
Thomas S Dexheimer, Smitha Antony, Christophe Marchand, et al.
Cancer Research
|
October 19, 2007
Batracylin (NSC 320846), a dual inhibitor of DNA topoisomerases I and II induces histone gamma-H2AX as a biomarker of DNA damage
V Ashutosh Rao, Keli Agama, Susan Holbeck, et al.
Journal of Computer-Aided Molecular Design
|
December 3, 2013
Development of purely structure-based pharmacophores for the topoisomerase I-DNA-ligand binding pocket
Malgorzata N Drwal, Keli Agama, Yves Pommier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 20, 2012
A kinetic clutch governs religation by type IB topoisomerases and determines camptothecin sensitivity
Yeonee Seol, Hongliang Zhang, Yves Pommier, et al.
Journal of Medicinal Chemistry
|
November 25, 2010
Design, synthesis, and evaluation of dibenzo[c,h][1,6]naphthyridines as topoisomerase I inhibitors and potential anticancer agents
Evgeny Kiselev, Thomas S Dexheimer, Yves Pommier, et al.
Molecular and Cellular Biology
|
October 29, 2008
Death receptor-induced activation of the Chk2- and histone H2AX-associated DNA damage response pathways
Stéphanie Solier, Olivier Sordet, Kurt W Kohn, et al.
Drug Discovery Today. Disease Mechanisms
|
September 30, 2011
Mechanisms and inhibition of HIV integration
Christophe Marchand, Allison A Johnson, Elena Semenova, et al.
Page
of 63
Search research articles
Search
Showing results (71-80 of 626) with videos related to
Sort By:
Page
of 63
Current Topics in Medicinal Chemistry
|
September 15, 2009
HIV-1 IN inhibitors: 2010 update and perspectives
Christophe Marchand, Kasthuraiah Maddali, Mathieu Métifiot, et al.
Acta Pharmacologica Sinica
|
June 1, 2004
Abrogation of Chk1-mediated S/G2 checkpoint by UCN-01 enhances ara-C-induced cytotoxicity in human colon cancer cells
Rong-Guang Shao, Chun-Xia Cao, Yves Pommier
Nature Communications
|
January 19, 2025
Structural insights into human topoisomerase 3β DNA and RNA catalysis and nucleic acid gate dynamics
Xi Yang, Xuemin Chen, Wei Yang, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
May 14, 2008
Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy
Thomas S Dexheimer, Smitha Antony, Christophe Marchand, et al.
Cancer Research
|
October 19, 2007
Batracylin (NSC 320846), a dual inhibitor of DNA topoisomerases I and II induces histone gamma-H2AX as a biomarker of DNA damage
V Ashutosh Rao, Keli Agama, Susan Holbeck, et al.
Journal of Computer-Aided Molecular Design
|
December 3, 2013
Development of purely structure-based pharmacophores for the topoisomerase I-DNA-ligand binding pocket
Malgorzata N Drwal, Keli Agama, Yves Pommier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 20, 2012
A kinetic clutch governs religation by type IB topoisomerases and determines camptothecin sensitivity
Yeonee Seol, Hongliang Zhang, Yves Pommier, et al.
Journal of Medicinal Chemistry
|
November 25, 2010
Design, synthesis, and evaluation of dibenzo[c,h][1,6]naphthyridines as topoisomerase I inhibitors and potential anticancer agents
Evgeny Kiselev, Thomas S Dexheimer, Yves Pommier, et al.
Molecular and Cellular Biology
|
October 29, 2008
Death receptor-induced activation of the Chk2- and histone H2AX-associated DNA damage response pathways
Stéphanie Solier, Olivier Sordet, Kurt W Kohn, et al.
Drug Discovery Today. Disease Mechanisms
|
September 30, 2011
Mechanisms and inhibition of HIV integration
Christophe Marchand, Allison A Johnson, Elena Semenova, et al.
Page
of 63